Maryland Gets $3.5 Million in Indivior Opioid Settlement
State of MD - Maryland has reached a finalized settlement worth $3.5 million with Indivior, a company that makes drugs used to treat opioid use disorder, Attorney General Anthony G. Brown announced. The agreement was entered as a consent judgment in the Circuit Court for Frederick County.
Under the deal, Maryland and its local subdivisions will get more than $1.5 million in opioid abatement funds. The state will also receive $2 million worth of medication used to treat opioid use disorder.
Both the money and the medicine are set aside for treatment. The state and its subdivisions plan to use them to add treatment resources and keep up the fight against the opioid epidemic.
Indivior makes, markets, and sells buprenorphine products. These products are approved to treat opioid use disorder, and with the right medical care and support, they can help people who are trying to recover.
The state's case was about how the company sold those products. In a complaint filed on November 6, 2026, Maryland alleged that Indivior marketed its products the wrong way and didn't keep watch on suspicious orders.
Attorney General Brown spoke about the outcome in a statement.
"Drug manufacturers must be held accountable for irresponsibly marketing their products," said Attorney General Brown. "Our agreement sets limits on Indivior's promotions and delivers millions of dollars in treatment to Maryland communities ravaged by the Opioid Epidemic."
The payment is only one part of the deal. The settlement also places a set of injunctive terms on Indivior, which are court-ordered rules the company has to follow.
Among them, Indivior has to cut back on some of its promotional activities. Any promotion the company does must be truthful, and it can't encourage misuse of its products.
The terms also cover how the company handles its sales staff. Indivior can't tie a salesperson's pay or discipline to how much of its opioid use disorder products they sell.